Annual Total Long Term Liabilities
$20.26 M
-$6.23 M-23.51%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual total long term liabilities is $20.26 million, with the most recent change of -$6.23 million (-23.51%) on December 31, 2023.
- During the last 3 years, SCNI annual total long term liabilities has risen by +$17.99 million (+790.28%).
- SCNI annual total long term liabilities is now -56.65% below its all-time high of $46.74 million, reached on December 1, 2019.
Performance
SCNI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$866.00 K
-$19.60 M-95.77%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly total long term liabilities is $866.00 thousand, with the most recent change of -$19.60 million (-95.77%) on September 1, 2024.
- Over the past year, SCNI quarterly long term liabilities has dropped by -$19.38 million (-95.72%).
- SCNI quarterly long term liabilities is now -98.15% below its all-time high of $46.74 million, reached on December 1, 2019.
Performance
SCNI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SCNI Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.5% | -95.7% |
3 y3 years | +790.3% | -96.7% |
5 y5 years | -33.8% | -96.7% |
SCNI Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -29.2% | at low | -97.0% | at low |
5 y | 5-year | -56.6% | +790.3% | -98.2% | at low |
alltime | all time | -56.6% | >+9999.0% | -98.2% | +5381.0% |
Scinai Immunotherapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $866.00 K(-95.8%) |
Jun 2024 | - | $20.46 M(+1.1%) |
Mar 2024 | - | $20.24 M(-0.1%) |
Dec 2023 | $20.26 M(-23.5%) | $20.26 M(+2.7%) |
Sep 2023 | - | $19.74 M(-21.4%) |
Jun 2023 | - | $25.12 M(-1.6%) |
Mar 2023 | - | $25.52 M(-3.6%) |
Dec 2022 | $26.49 M(-7.4%) | $26.49 M(+57.1%) |
Sep 2022 | - | $16.87 M(+1.7%) |
Jun 2022 | - | $16.59 M(-25.6%) |
Mar 2022 | - | $22.28 M(-22.1%) |
Dec 2021 | $28.61 M(+1157.1%) | - |
Dec 2021 | - | $28.61 M(+1302.7%) |
Sep 2021 | - | $2.04 M(-8.7%) |
Jun 2021 | - | $2.24 M(+3.5%) |
Mar 2021 | - | $2.16 M(-5.1%) |
Dec 2020 | $2.28 M(-95.1%) | $2.28 M(-88.0%) |
Sep 2020 | - | $19.02 M(-53.6%) |
Jun 2020 | - | $40.98 M(+1.4%) |
Mar 2020 | - | $40.43 M(-13.5%) |
Dec 2019 | $46.74 M | $46.74 M(+19.1%) |
Sep 2019 | - | $39.24 M(+1.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $38.69 M(+24.5%) |
Mar 2019 | - | $31.08 M(+1.6%) |
Dec 2018 | $30.60 M(+473.1%) | $30.60 M(+74.0%) |
Sep 2018 | - | $17.59 M(+53.0%) |
Jun 2018 | - | $11.50 M(+95.5%) |
Mar 2018 | - | $5.88 M(+10.1%) |
Dec 2017 | $5.34 M(+558.6%) | $5.34 M(+58.3%) |
Sep 2017 | - | $3.37 M(-35.7%) |
Jun 2017 | - | $5.25 M(+74.1%) |
Mar 2017 | - | $3.01 M(+271.8%) |
Dec 2016 | $810.80 K(-47.8%) | $810.80 K(-15.5%) |
Sep 2016 | - | $959.40 K(-25.9%) |
Jun 2016 | - | $1.30 M(+6.2%) |
Mar 2016 | - | $1.22 M(-21.5%) |
Dec 2015 | $1.55 M(+9668.6%) | $1.55 M(-11.9%) |
Sep 2015 | - | $1.76 M(-16.9%) |
Jun 2015 | - | $2.12 M(>+9900.0%) |
Mar 2015 | - | $16.20 K(+1.9%) |
Dec 2014 | $15.90 K(+0.6%) | $15.90 K(-4.2%) |
Sep 2014 | - | $16.60 K(+5.1%) |
Dec 2013 | $15.80 K(+23.4%) | $15.80 K |
Dec 2012 | $12.80 K | - |
FAQ
- What is Scinai Immunotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual total long term liabilities year-on-year change?
- What is Scinai Immunotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly long term liabilities year-on-year change?
What is Scinai Immunotherapeutics annual total long term liabilities?
The current annual total long term liabilities of SCNI is $20.26 M
What is the all time high annual total long term liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual total long term liabilities is $46.74 M
What is Scinai Immunotherapeutics annual total long term liabilities year-on-year change?
Over the past year, SCNI annual total long term liabilities has changed by -$6.23 M (-23.51%)
What is Scinai Immunotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SCNI is $866.00 K
What is the all time high quarterly long term liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly total long term liabilities is $46.74 M
What is Scinai Immunotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, SCNI quarterly total long term liabilities has changed by -$19.38 M (-95.72%)